For the two calendar years covering the roll-out of its toxic C19 mRNA injections, Moderna had sales of 37.5 billion bucks that cost it 8.6 billion bucks to make – leaving gross margin of around 29 billion bucks.
Moderna paid taxes of 3.1 billion over the last two years, negligible in prior years. Last two calendar years, 29 billion in gross margin, 3.1 billion in taxes = tax rate of 10.5%.
The Great Moderna Pricing Ripoff…
